South and Central America Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Range, Route of Administration, Indication, and Distribution Channel

List of Tables

The South & Central America anti-infective agents market is projected to grow from US$ 5,713.39 million in 2022 to US$ 6,498.70 million by 2028, at a CAGR of 2.2% during the forecast period.

In South & Central America, the market exhibits growth opportunities with progressive developments in Brazil, such as growing medical tourism and an increasing number of government initiatives to create awareness about anti-infective agents. The growing prevalence of infectious diseases is a major concern among the Brazilian population, thereby increasing the demand for anti-infective agents. These factors stimulate the growth of the anti-infective agent market in this region.

A few major countries contributing to the growth of the anti-infective agents market include Chile, Colombia, Peru, and Bolivia. The aging population, high prevalence of osteoporosis, and growing number of orthopedic surgeries are prime factors for the market growth. The presence of international healthcare technology players further strengthens the market's growth in the region. For instance, Surbiton reaffirms its position as Argentina's flagship Company in the field of medical devices of international quality. Moreover, the company has an active presence in several countries, including Peru, Colombia, and Argentina. Such developments are estimated to contribute to the growth of the Rest of the South & Central America anti-infective agents anti-infective agents market during the forecast period.

Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the South & Central America anti-infective agents market at a good CAGR during the forecast period.

South & Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Anti-Infective Agents Market Segmentation

The South & Central America anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.

Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.

Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.

Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to hold the largest market share by the end of 2022.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the South & Central America anti-infective agents market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America anti-infective agents market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South &; Central America anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025837

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Anti-Infective Agents Market - By Type
- 1.3.2 SAM Anti-Infective Agents Market - By Range
- 1.3.3 SAM Anti-Infective Agents Market - By Route of Administration
- 1.3.4 SAM Anti-Infective Agents Market - By Indication
- 1.3.5 SAM Anti-Infective Agents Market - By Distribution Channel
- 1.3.6 SAM Anti-Infective Agents Market - By Country

2. SAM Anti-Infective Agents Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Anti-infective agents Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion

5. SAM Anti-Infectives Agents Market - Key Market Dynamics

5.1 Key Drivers
- 5.1.1 Chronic Diseases Rising
- 5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
- 5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
- 5.3.1 Development of Advanced Anti-infective Agents
5.4 Future Trends
- 5.4.1 R&D Activities in Pharmaceutical Sector Witnessing High Investments
5.5 Impact Analysis

6. Anti-Infectives Agents Market - SAM Analysis

6.1 SAM Anti-Infectives Agents Market Revenue Forecast and Analysis

7. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 - Type Overview

7.1 SAM Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.2 Anti-Viral
- 7.2.1 Overview
- 7.2.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.3 Anti-Bacterial
- 7.3.1 Overview
- 7.3.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Fungal
- 7.4.1 Overview
- 7.4.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 - Range

8.1 Overview
8.2 SAM Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
- 8.3.1 Overview
- 8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
- 8.4.1 Overview
- 8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 - Route of Administration

9.1 Overview
9.2 SAM Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
- 9.3.1 Overview
- 9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
- 9.4.1 Overview
- 9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
- 9.5.1 Overview
- 9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 - Indication

10.1 Overview
10.2 SAM Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
- 10.3.1 Overview
- 10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
- 10.4.1 Overview
- 10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
- 10.5.1 Overview
- 10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
- 10.6.1 Overview
- 10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 - Distribution Channel

11.1 Overview
11.2 SAM Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
- 11.3.1 Overview
- 11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
- 11.4.1 Overview
- 11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
- 11.5.1 Overview
- 11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
- 11.6.1 Overview
- 11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
- 11.7.1 Overview
- 11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. SAM Anti-Infectives Agents Market Analysis and Forecasts To 2028 - Country Analysis

12.1 Overview
- 12.1.2 SAM Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
  - 12.1.2.1 Brazil: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.1 Overview
    - 12.1.2.1.2 Brazil Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.3 Brazil: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.2.1.4 Brazil: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.2.1.5 Brazil: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.2.1.6 Brazil: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.2.1.7 Brazil: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.2.2 Argentina: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.1 Overview
    - 12.1.2.2.2 Argentina Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.3 Argentina: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.2.2.4 Argentina: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.2.2.5 Argentina: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.2.2.6 Argentina: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.2.2.7 Argentina: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.2.3 Rest of the SAM: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.1 Overview
    - 12.1.2.3.2 Rest of the SAM Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.3 Rest of the SAM: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.2.3.4 Rest of the SAM: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.2.3.5 Rest of the SAM: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.2.3.6 Rest of the SAM: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.2.3.7 Rest of the SAM: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)

13. Anti-infectives Agents Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
- 13.3.1 Overview
- 13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
- 13.4.1 Overview
- 13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14. Anti-Infectives Agents Market- Company Profiles

14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Allergan Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Astellas Pharma Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Merck & Co., Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bayer AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Novartis AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms